Medicine and Dentistry
Radiation Therapy
100%
Neoplasm
60%
Stereotactic Body Radiation Therapy
39%
Disease
37%
Non Small Cell Lung Cancer
34%
Overall Survival
26%
Malignant Neoplasm
21%
Lung Cancer
17%
Intensity Modulated Radiation Therapy
16%
Surgery
16%
Metastatic Carcinoma
14%
Recurrent Disease
14%
Pediatrics
14%
Childhood Cancer
13%
Oncology
13%
Medulloblastoma
13%
Chemoradiotherapy
11%
Drug Megadose
11%
Stereotactic Radiosurgery
11%
Neck
11%
Clinical Trial
11%
Brain Tumor
11%
Head and Neck Cancer
10%
Breast Cancer
10%
Ganglioglioma
10%
Treatment Planning
10%
Brachytherapy
9%
Cervical Cancer
9%
Prostate Cancer
9%
Hodgkin's Lymphoma
8%
Progression Free Survival
8%
Magnetic Resonance Imaging
8%
External Beam Radiotherapy
7%
Cancer
7%
Hazard Ratio
7%
Primary Tumor
6%
Pediatric Brain Tumor
6%
Computer Assisted Tomography
6%
Radiation Oncology
6%
Positron Emission Tomography
6%
Glioblastoma
6%
Acute Lymphoblastic Leukemia
6%
Pediatrics Patient
6%
Health Care Cost
6%
Cisplatin
6%
Survival Rate
6%
Brain Metastasis
6%
Central Nervous System
5%
Phase II Trials
5%
Central Nervous System Tumor
5%
Distant Metastasis
5%
Ependymoma
5%
Multimodality Cancer Therapy
5%
Craniospinal Irradiation
5%
Partial Breast Irradiation
5%
Cost-Effectiveness Analysis
5%
Brainstem
5%
Positron Emission Tomography-Computed Tomography
5%
Carboplatin
5%
Arm
5%
Squamous Cell Carcinoma
5%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
37%
Neoplasm
32%
Chemotherapy
25%
Disease
23%
Malignant Neoplasm
22%
Overall Survival
20%
Chemoradiation Therapy
18%
Paclitaxel
15%
Lung Cancer
14%
Brain Tumor
13%
Carboplatin
9%
Clinical Trial
8%
Recurrent Disease
7%
Prostate Cancer
7%
Cisplatin
7%
Childhood Cancer
7%
Progression Free Survival
6%
Phase II Trials
6%
Survival Rate
6%
Head and Neck Cancer
5%
Maximum Tolerated Dose
5%
Medulloblastoma
5%
Metastasis
5%
Keyphrases
Radiation Therapy
24%
Chemotherapy
14%
Tumor
13%
Non-small Cell Lung Cancer (NSCLC)
13%
Overall Survival
10%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
9%
Radiotherapy
9%
Phase II Study
9%
Stereotactic Body Radiation Therapy
8%
Irradiation
8%
Paclitaxel
7%
Pediatric Brain Tumor
7%
Pediatric Oncology
7%
Stereotactic Ablative Radiotherapy
7%
Combined Modality Therapy
6%
Medulloblastoma
6%
Carboplatin
6%
Head-and-neck Cancer
5%
Progression-free Survival
5%
Newly Diagnosed
5%
Phase II Trial
5%